NEWS
HPV Vaccine Study in Costa Rica Yields Insights on Cancer Prevention
A flurry of new research findings on a vaccine that prevents persistent infections by cancer-causing types of the human papillomavirus (HPV) has confirmed the vaccine's efficacy and opened new avenues for research. The results, published in three separate reports, suggest that the vaccine could be simpler to administer and more affordable than researchers had thought previously—and the vaccine may also have unexpected benefits. Read more > >
For Young Women, Breast Conserving Surgery May Be Acceptable Alternative to Mastectomy
Two studies show recurrence and survival rates are similar after both proceduresFluorescent Probe Helps Surgeons Find Ovarian Cancer Cells
In a proof-of-concept study, probe helped distinguish tumor from normal tissueNurse Practitioners, Physician Assistants Could Alleviate Projected Oncology Workforce Shortage
Surveyed patients and staff are satisfied with collaborative care arrangementsStudy Suggests How the BRCA1 Protein May Help Suppress Tumors
By silencing DNA, the protein may preserve the integrity of the genomeBacterium Associated with Stomach Cancer Directly Damages DNA
DNA damage followed by imprecise repair may contribute to gastric cancer development
COMMENTARY
A Conversation with Dr. Ted Trimble on NCI's Center for Global Health 
The director of NCI's new Center for Global Health explains why the center was formed and discusses the institute's global strategy for engaging the research community and other partners worldwide to ensure that cancer research has a global reach. 
IN DEPTH
In Breast Cancer, Moving Toward More Personalized Hormone Therapies
Study urges doctors to consider side effects and health history when selecting a drug
Unpublished Phase III Cancer Trials: Eliminating the Negative?
Negative results that go unpublished cause publication bias and may affect patient treatment decisions
Featured Clinical Trial: Studying the Natural Course of Precursor Conditions to Multiple Myeloma
Are there biological markers that can identify people at risk of progression?
Researchers Discuss State of the Science on Myelodysplastic Syndromes
Participants identified areas of research that would benefit from new funding
UPDATES
FDA Update
- Health Officials Issue Statement on Drug Shortages
- Cancer Therapies Office Reorganized
Cancer.gov Update
- NCI Recovery Act Website Highlights Training in Comparative Effectiveness Research
Notes
- Appointments Announced for Two New NCI Centers, Division of Cancer Prevention
- NCI's Norm Coleman Wins Service to America Medal
- Director's Consumer Liaison Group Meets this Week
- NCI, HHS Launch Mobile Services to Help Smokers Quit
Selected articles from past issues of the NCI Cancer Bulletin are available in Spanish.
The NCI Cancer Bulletin is produced by the National Cancer Institute (NCI), which was established in 1937. Through basic, clinical, and population-based biomedical research and training, NCI conducts and supports research that will lead to a future in which we can identify the environmental and genetic causes of cancer, prevent cancer before it starts, identify cancers that do develop at the earliest stage, eliminate cancers through innovative treatment interventions, and biologically control those cancers that we cannot eliminate so they become manageable, chronic diseases.
For more information about cancer, call 1-800-4-CANCER or visit http://www.cancer.gov.
NCI Cancer Bulletin staff can be reached at ncicancerbulletin@mail.nih.gov.
